Risk of bevacizumab-associated gastrointestinal perforation in patients with colorectal cancer and noncolorectal cancer

被引：0
|
作者：
Chu, D. T. [1 ]
Hapani, S. [1 ]
Wu, S. [1 ]
机构：
[1] Stony Brook Univ Hosp, Stony Brook, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9622
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Risk of thromboembolism associated with an angiogenesis inhibitor bevacizumab in cancer patients
    Chu, D. T.
    Nalluri, S. R.
    Wu, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Gastrointestinal Perforation and Fistula Formation in 5 Patients With Colorectal Cancer During Treatment With Regorafenib
    Doi, Ayako
    Kuboki, Yasutoshi
    Shitara, Kohei
    Fukuoka, Shota
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    CLINICAL COLORECTAL CANCER, 2017, 16 (02) : E109 - E113
  • [43] BEVACIZUMAB-ASSOCIATED HEMOPTYSIS IN COLORECTAL CARCINOMA WITH MULTIPLE LUNG METASTASES: A CASE REPORT
    Shiraishi, T.
    Tanaka, T.
    Takahashi, I.
    Fukuhara, K.
    Inoue, H.
    Shimabukuro, R.
    Maruyama, S.
    Ikeda, Y.
    Yamaguchi, I.
    Hashimoto, H.
    Murakami, H.
    Kanematsu, T.
    Fujisaki, T.
    Nishizaki, T.
    Fujii, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 148 - 148
  • [44] Bevacizumab-induced bleeding in colorectal and noncolorectal cancer patients in a community oncology setting: An Abington Memorial Hospital experience.
    Ali, Naveed
    Malik, Faizan
    Naglak, Mary
    Jafri, Syed Imran Mustafa
    Fidler, Christian
    Shahin, Mark S.
    Seidman, Michael J.
    Cohen, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Gastrointestinal (GI) ulceration as a possible side effect of treatment with bevacizumab in advanced colorectal cancer which may herald perforation
    Tol, J.
    Cats, A.
    Mol, L.
    Koopman, M.
    Antonini, N. F.
    Van Krieken, J. H. J. M.
    Punt, C. J. A.
    ANNALS OF ONCOLOGY, 2008, 19 : I45 - I46
  • [46] Bevacizumab in elderly patients with metastatic colorectal cancer
    Sclafani, Francesco
    Cunningham, David
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 78 - 88
  • [47] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Cherciu, Nelly
    Petria, Cristina
    ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
  • [48] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Benedik, Jernej
    Volk, Neva
    ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [49] Bevacizumab safety in Japanese patients with colorectal cancer
    Hatake, Kiyohiko
    Doi, Toshihiko
    Uetake, Hiroyuki
    Takahashi, Yoichiro
    Ishihara, Yumi
    Shirao, Kuniaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 234 - 240
  • [50] Bevacizumab in colorectal cancer
    Sharieff, W
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (16): : 1690 - 1690
12345